Matches in Wikidata for { <http://www.wikidata.org/entity/Q104137817> ?p ?o ?g. }
Showing items 1 to 48 of
48
with 100 items per page.
- Q104137817 description "2020 ވަނަ އަހަރުގެ ނޮވެމްބަރުމަހުގެ 1ވަނަ ދުވަހު ޝާއިރުކުރެވުނު ސައިންޓިފިކް ލިޔުމެއް" @default.
- Q104137817 description "artículu científicu espublizáu en payares de 2020" @default.
- Q104137817 description "im November 2020 veröffentlichter wissenschaftlicher Artikel" @default.
- Q104137817 description "scientific article published on 01 November 2020" @default.
- Q104137817 description "wetenschappelijk artikel" @default.
- Q104137817 description "наукова стаття, опублікована 1 листопада 2020" @default.
- Q104137817 name "Frequency and Reasons for Non-Administration and Suspension of Drugs During an Acute Coronary Syndrome Event. The ERICO Study" @default.
- Q104137817 name "Frequency and Reasons for Non-Administration and Suspension of Drugs During an Acute Coronary Syndrome Event. The ERICO Study" @default.
- Q104137817 name "Frequency and Reasons for Non-Administration and Suspension of Drugs During an Acute Coronary Syndrome Event. The ERICO Study" @default.
- Q104137817 type Item @default.
- Q104137817 label "Frequency and Reasons for Non-Administration and Suspension of Drugs During an Acute Coronary Syndrome Event. The ERICO Study" @default.
- Q104137817 label "Frequency and Reasons for Non-Administration and Suspension of Drugs During an Acute Coronary Syndrome Event. The ERICO Study" @default.
- Q104137817 label "Frequency and Reasons for Non-Administration and Suspension of Drugs During an Acute Coronary Syndrome Event. The ERICO Study" @default.
- Q104137817 prefLabel "Frequency and Reasons for Non-Administration and Suspension of Drugs During an Acute Coronary Syndrome Event. The ERICO Study" @default.
- Q104137817 prefLabel "Frequency and Reasons for Non-Administration and Suspension of Drugs During an Acute Coronary Syndrome Event. The ERICO Study" @default.
- Q104137817 prefLabel "Frequency and Reasons for Non-Administration and Suspension of Drugs During an Acute Coronary Syndrome Event. The ERICO Study" @default.
- Q104137817 P1433 Q104137817-E8A5DB8B-D82B-42D2-8C8D-99EFD7FEB0C7 @default.
- Q104137817 P1476 Q104137817-8EDD4255-1E54-4D56-A9DB-6FF2E01DB540 @default.
- Q104137817 P2093 Q104137817-0A178DD0-F6D5-4558-B8D6-5F0FED3AD693 @default.
- Q104137817 P304 Q104137817-C1B5D93D-1F8E-49BF-B39D-F35BFE4F2033 @default.
- Q104137817 P31 Q104137817-412AA02D-1A9A-4A06-8689-35E8233140BD @default.
- Q104137817 P356 Q104137817-8632FF75-6B1F-4C5E-BA40-5174B32191D7 @default.
- Q104137817 P433 Q104137817-299AACA9-CECA-4D5B-9079-DF0BE6439584 @default.
- Q104137817 P478 Q104137817-3DE9EE63-4095-4A31-A049-B22BE5BD5258 @default.
- Q104137817 P50 Q104137817-37B530E1-8549-49F1-A949-1B82701521BC @default.
- Q104137817 P50 Q104137817-42E4F622-A444-4105-90EB-8166001DFF52 @default.
- Q104137817 P50 Q104137817-6A4F77CF-3D2C-4317-BFCC-0A36ADEB935F @default.
- Q104137817 P50 Q104137817-BC02AF92-F942-4A37-A9C5-2D19FE2A4B9F @default.
- Q104137817 P577 Q104137817-D0EB3468-8025-49DC-BC6A-714FC2E92D6E @default.
- Q104137817 P698 Q104137817-BD20EA0C-C8D1-4A0A-ADA5-8BE990275697 @default.
- Q104137817 P921 Q104137817-391D601D-886C-4360-832D-7940405155F4 @default.
- Q104137817 P356 ABC.20190317 @default.
- Q104137817 P698 33295445 @default.
- Q104137817 P1433 Q2669813 @default.
- Q104137817 P1476 "Frequency and Reasons for Non-Administration and Suspension of Drugs During an Acute Coronary Syndrome Event. The ERICO Study" @default.
- Q104137817 P2093 "Rafael C O Santos" @default.
- Q104137817 P304 "830-839" @default.
- Q104137817 P31 Q13442814 @default.
- Q104137817 P356 "10.36660/ABC.20190317" @default.
- Q104137817 P433 "5" @default.
- Q104137817 P478 "115" @default.
- Q104137817 P50 Q37367644 @default.
- Q104137817 P50 Q42305942 @default.
- Q104137817 P50 Q87298673 @default.
- Q104137817 P50 Q89778638 @default.
- Q104137817 P577 "2020-11-01T00:00:00Z" @default.
- Q104137817 P698 "33295445" @default.
- Q104137817 P921 Q266018 @default.